Page 8 of lupin

Lupin, Lupin Limited, Asthma, fixed-dose triple drug combination, health news, pharma news,

Lupin launches fixed-dose triple drug combination to treat uncontrolled asthma

According to the pharma major, DIFIZMA will help in the management of inadequately controlled asthma by improving lung function, providing…

January 5, 2023 13:15 IST

Lupin, Lupin Limited, Regional Reference Laboratory, health news, pharma news, diagnostics news,

Lupin Diagnostics launches Regional Reference Laboratory in Indore

These labs are equipped with qualified clinical experts and automated, streamlined processes so patients can make informed decisions about their…

December 21, 2022 17:23 IST

Novartis, Heart failure, patent expiry, Indian cardiac market, healthcare news, pharma news,

Some Biosimilar products help in increasing neutrophil counts of cancer patients, which helps to boost the immune system and reduce…

December 18, 2022 20:41 IST

Lupin, Lupin limited, Lupin appointments, generic business, health news, pharma news,

Lupin appoints Spiro Gavaris as President of U.S. Generics business

Spiro joins Lupin with significant experience in the branded, generic and biotech industries, the company stated.

December 9, 2022 17:05 IST

Lupin launches generic version of Horizon Pharma’s anti-inflammatory drug in United States

According to IQVIA MAT October 2022, Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of USD…

December 9, 2022 15:16 IST

Lupin launches anti-seizure tablets in United States

According to IQVIA MAT October 2022, Rufinamide Tablets (RLD Banzel) had estimated annual sales of USD 138 million in the…

December 5, 2022 14:51 IST

Lupin’s Brazilian subsidiary, MedQuimica acquires rights to 9 brands from Bausch Health

This move reinforces our commitment to making healthcare solutions accessible to all patients, the company claimed.

November 28, 2022 18:14 IST

Nevertheless, at current valuations, closure/divestment of underutilised assets poses an upside risk. Retain ADD with a raised fair value of Rs 750.

Lupin Rating: Add | Margin recovery set to continue in the near term

The company expects India to grow in double digits in FY2024

November 14, 2022 04:50 IST

Lupin’s revenue rises to Rs. 4,145 crore in Q2; Net profit of Rs. 130 crore

Meanwhile, global API Sales for Q2 FY2023 were INR 2,499 mn, down 2 percent as compared to INR 2,551 mn…

November 10, 2022 11:10 IST

USFDA tentatively approves Lupin’s anti-bacterial infection capsules

Doxycycline Capsules (RLD Oracea) had estimated annual sales of USD 215 million in the U.S., as per IQVIA MAT September…

November 8, 2022 15:33 IST

USFDA tentatively approves Lupin’s birth control tablets

Drospirenone Tablets (RLD Slynd) had estimated annual sales of USD 141 million in the United States, as per IQVIA MAT…

November 7, 2022 12:08 IST

Lupin, Sunovion, inhalation brands, health news, pharma news,

Lupin inks agreement to acquire two inhalation brands from Sunovion

The pharma also announced that it expects the transaction to be accretive to earnings in the first year.

October 21, 2022 15:55 IST

Lupin launches new drug for schizophrenia treatment in United States

Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 112 million in the U.S. (IQVIA MAT August 2022).

October 21, 2022 15:37 IST

Lancet Commission, Lancet Journal, Mental Health, Mental Health Awareness, health news, healthcare news,

Start them young: The importance of mental health awareness among adolescents

According to UNICEF, children with mental health disorders remain largely undiagnosed, because most parents are hesitant in seeking help or…

October 12, 2022 11:36 IST

Lupin, Lupin Limited, USFDA, generic drugs, health news, pharma news,

USFDA approves Lupin’s generic version of HIV/AIDS tablets

Darunavir is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.

October 4, 2022 13:46 IST

USFDA approves Lupin’s extended release tablets for overactive bladder

Mirabegron is indicated to treat overactive bladder or neurogenic detrusor overactivity but does not cure these conditions.

September 29, 2022 17:23 IST

Lupin, Lupin Limited, Sildenafil, erectile dysfunction, Pfizer, Viagra, Health news, pharma news,

Lupin launches oral drug for erectile dysfunction in United States

Sildenafil for oral suspension (RLD Revatio) had estimated annual sales of USD 64 million in the U.S. (IQVIA MAT July…

September 29, 2022 15:14 IST

USFDA approves Lupin’s generic version of Pennsaid for arthritic knee pain

Diclofenac topical solution (Pennsaid) is prescribed to relieve osteoarthritis pain in the knees.

September 22, 2022 15:38 IST

Related News

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

US Supreme Court won't review rule allowing H-1B holders' spouses to work

Big relief for spouses of H-1B visa holders as US Supreme Court rejects challenge to H-4 work rule

What is SB 509? Controversial ‘anti-India’ bill vetoed by California Gov Newsom

TCS HR Chief Clarifies Layoff Speculation: 'Not Chasing a Target,' Involuntary Attrition to Continue.

TCS Layoffs update: HR Head Sudeep Kunnumal says ‘we’ll continue to…’

Airtel, IBM tie up for enterprise cloud solutions

Business51 min ago

Bharti Airtel and IBM have partnered to enhance Airtel Cloud with IBM’s AI and hybrid cloud technologies, catering to regulated industries like banking, healthcare, and government. This collaboration will offer Airtel Cloud customers access to IBM Power systems and support for enterprise workloads, while establishing two new multizone regions in Mumbai.

View all shorts